Royal Bank of Canada’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-238
| Closed | – | – | 7425 |
|
|
2018
Q4 | $0 | Hold |
238
| – | – | ﹤0.01% | 7551 |
|
|
2018
Q3 | $0 | Buy |
238
+13
| +6% | +$22 | ﹤0.01% | 7240 |
|
|
2018
Q2 | $0 | Buy |
225
+122
| +118% | +$299 | ﹤0.01% | 7070 |
|
|
2018
Q1 | $0 | Hold |
103
| – | – | ﹤0.01% | 7246 |
|
|
2017
Q4 | $0 | Hold |
103
| – | – | ﹤0.01% | 7344 |
|
|
2017
Q3 | $0 | Hold |
103
| – | – | ﹤0.01% | 7338 |
|
|
2017
Q2 | $0 | Hold |
103
| – | – | ﹤0.01% | 7101 |
|
|
2017
Q1 | $0 | Sell |
103
-10,000
| -99% | -$31.4K | ﹤0.01% | 7063 |
|
|
2016
Q4 | $20K | Hold |
10,103
| – | – | ﹤0.01% | 5788 |
|
|
2016
Q3 | $63K | Sell |
10,103
-2,000
| -17% | -$12.3K | ﹤0.01% | 5052 |
|
|
2016
Q2 | $54K | Buy |
12,103
+10,000
| +476% | +$65.3K | ﹤0.01% | 5087 |
|
|
2016
Q1 | $22K | Sell |
2,103
-6
| -0.3% | -$119 | ﹤0.01% | 5456 |
|
|
2015
Q4 | $62K | Sell |
2,109
-166
| -7% | -$5.02K | ﹤0.01% | 5202 |
|
|
2015
Q3 | $71K | Sell |
2,275
-4,290
| -65% | -$205K | ﹤0.01% | 4963 |
|
|
2015
Q2 | $389K | Buy |
6,565
+5,019
| +325% | +$354K | ﹤0.01% | 3845 |
|
|
2015
Q1 | $165K | Buy |
+1,546
| New | +$147K | ﹤0.01% | 4347 |
|
|
2014
Q3 | – | Sell |
-8,971
| Closed | -$806K | – | 6273 |
|
|
2014
Q2 | $806K | Sell |
8,971
-5,029
| -36% | -$308K | ﹤0.01% | 3002 |
|
|
2014
Q1 | $749K | Buy |
+14,000
| New | +$462K | ﹤0.01% | 3016 |
|
|
2013
Q4 | – | Sell |
-38
| Closed | -$1K | – | 6347 |
|
|
2013
Q3 | $1K | Buy |
38
+17
| +81% | +$547 | ﹤0.01% | 6017 |
|
|
2013
Q2 | $1K | Buy |
+21
| New | +$787 | ﹤0.01% | 5774 |
|
Royal Bank of Canada's PTX Position: Q1 2019 in Review
Royal Bank of Canada sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q1 2019, closing a stake of 238 shares.
Royal Bank of Canada first reported a position in PTX in Q2 2013 and held it in 20 quarters. The position peaked at $806K in Q2 2014. 1 fund tracked by Wall St. Rank holds PTX as of Q1 2019.
- Royal Bank of Canada reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q1 2019 after selling out during the quarter.
- Royal Bank of Canada sold 238 Pernix Therapeutics Holdings, Inc. shares in Q1 2019.
- Royal Bank of Canada first reported a position in Pernix Therapeutics Holdings, Inc. in Q2 2013 and held it in 20 quarters.
- Royal Bank of Canada's Pernix Therapeutics Holdings, Inc. position peaked at $806K in Q2 2014.
- 1 fund tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q1 2019.
Based on Royal Bank of Canada's 13F filing for Q1 2019, filed 15 May 2019.